Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Epilepsia Open|March 7, 2020
Limited efficacy of zonisamide in the treatment of refractory infantile spasmsShaun A Hussain, Mario Navarro, Jaeden Heesch, et al.
Epilepsy Research|February 15, 2020
Felbamate in the treatment of refractory epileptic spasmsShaun A Hussain, Brenda Asilnejad, Jaeden Heesch, et al.
Frontiers in Cell and Developmental Biology|April 13, 2023
Myristate induces mitochondrial fragmentation and cardiomyocyte hypertrophy through mitochondrial E3 ubiquitin ligase MUL1César Vásquez-Trincado, Mario Navarro-Márquez, Pablo E Morales, et al.
Archives of Osteoporosis|December 4, 2025
Burden of disease and trend of osteoporotic fall-related hip fractures in Ecuador: findings from the global burden disease 2021Enrique Lopez Gavilanez, Manuel Navarro Chávez, Noemí LitardoBautista Litardo, et al.
Cureus|September 2, 2024
Navigating Prevention: A Systematic Review of Strategies for Alzheimer's Disease in High-Risk and Affected IndividualsCarlos Luis Guanín Cabrera, Arturo P Jaramillo, Maria P Vallejo, et al.
Toxins|February 11, 2016
Apoptosis Activation in Human Lung Cancer Cell Lines by a Novel Synthetic Peptide Derived from Conus californicus VenomIrasema Oroz-Parra, Mario Navarro, Karla E Cervantes-Luevano, et al.
Pharmacological Research|May 17, 2019
GDF-11 prevents cardiomyocyte hypertrophy by maintaining the sarcoplasmic reticulum-mitochondria communicationValeria Garrido-Moreno, Alexis Díaz-Vegas, Camila López-Crisosto, et al.
Archives of Osteoporosis|April 3, 2026
Post-pandemic acceleration in osteoporotic hip fracture burden in Ecuador: a joinpoint analysis of Global Burden of Disease data, 2010-2023Enrique Lopez Gavilanez, Manuel Navarro Chávez, Mario Hernández Bonilla, et al.
International Journal of Molecular Sciences|May 7, 2025
New Perspectives on the Molecular Action of Metformin in the Context of Cellular Transduction and AdipogenesisJorge Enrique González-Casanova, Mario Navarro-Marquez, Tamara Saez-Tamayo, et al.
Scientific Reports|October 19, 2017
Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradationNatalia Torrealba, Mario Navarro-Marquez, Valeria Garrido, et al.
Pageof 4